Literature DB >> 35638693

Abnormal intestinal milieu in posttraumatic stress disorder is not impacted by treatment that improves symptoms.

Robin M Voigt1,2,3, Alyson K Zalta4,5, Shohreh Raeisi1, Lijuan Zhang1, J Mark Brown6,7,8,9, Christopher B Forsyth1,2,3, Randy A Boley5, Philip Held5, Mark H Pollack4, Ali Keshavarzian1,2,3,10.   

Abstract

Posttraumatic stress disorder (PTSD) is a psychiatric disorder, resulting from exposure to traumatic events. Current recommended first-line interventions for the treatment of PTSD include evidence-based psychotherapies, such as cognitive processing therapy (CPT). Psychotherapies are effective for reducing PTSD symptoms, but approximately two-thirds of veterans continue to meet diagnostic criteria for PTSD after treatment, suggesting there is an incomplete understanding of what factors sustain PTSD. The intestine can influence the brain and this study evaluated intestinal readouts in subjects with PTSD. Serum samples from controls without PTSD (n = 40) from the Duke INTRuST Program were compared with serum samples from veterans with PTSD (n = 40) recruited from the Road Home Program at Rush University Medical Center. Assessments included microbial metabolites, intestinal barrier, and intestinal epithelial cell function. In addition, intestinal readouts were assessed in subjects with PTSD before and after a 3-wk CPT-based intensive treatment program (ITP) to understand if treatment impacts the intestine. Compared with controls, veterans with PTSD had a proinflammatory intestinal environment including lower levels of microbiota-derived metabolites, such as acetic, lactic, and succinic acid, intestinal barrier dysfunction [lipopolysaccharide (LPS) and LPS-binding protein], an increase in HMGB1, and a concurrent increase in the number of intestinal epithelial cell-derived extracellular vesicles. The ITP improved PTSD symptoms but no changes in intestinal outcomes were noted. This study confirms the intestine is abnormal in subjects with PTSD and suggests that effective treatment of PTSD does not alter intestinal readouts. Targeting beneficial changes in the intestine may be an approach to enhance existing PTSD treatments.NEW & NOTEWORTHY This study confirms an abnormal intestinal environment is present in subjects with PTSD. This study adds to what is already known by examining the intestinal barrier and evaluating the relationship between intestinal readouts and PTSD symptoms and is the first to report the impact of PTSD treatment (which improves symptoms) on intestinal readouts. This study suggests that targeting the intestine as an adjunct approach could improve the treatment of PTSD.

Entities:  

Keywords:  HMGB1; extracellular vesicles; intestinal barrier; intestinal microbiota; posttraumatic stress disorder

Mesh:

Year:  2022        PMID: 35638693      PMCID: PMC9291416          DOI: 10.1152/ajpgi.00066.2022

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.871


  91 in total

1.  Psychometric properties of the PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (PCL-5) in veterans.

Authors:  Michelle J Bovin; Brian P Marx; Frank W Weathers; Matthew W Gallagher; Paola Rodriguez; Paula P Schnurr; Terence M Keane
Journal:  Psychol Assess       Date:  2015-12-14

2.  The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test.

Authors:  K Bush; D R Kivlahan; M B McDonell; S D Fihn; K A Bradley
Journal:  Arch Intern Med       Date:  1998-09-14

3.  A brief measure for assessing generalized anxiety disorder: the GAD-7.

Authors:  Robert L Spitzer; Kurt Kroenke; Janet B W Williams; Bernd Löwe
Journal:  Arch Intern Med       Date:  2006-05-22

Review 4.  Short overview on metabolomic approach and redox changes in psychiatric disorders.

Authors:  Gordana Nedic Erjavec; Marcela Konjevod; Matea Nikolac Perkovic; Dubravka Svob Strac; Lucija Tudor; Coral Barbas; Tilman Grune; Neven Zarkovic; Nela Pivac
Journal:  Redox Biol       Date:  2017-09-06       Impact factor: 11.799

5.  Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology and neurocognition in healthy volunteers.

Authors:  A P Allen; W Hutch; Y E Borre; P J Kennedy; A Temko; G Boylan; E Murphy; J F Cryan; T G Dinan; G Clarke
Journal:  Transl Psychiatry       Date:  2016-11-01       Impact factor: 6.222

6.  Evaluating patterns and predictors of symptom change during a three-week intensive outpatient treatment for veterans with PTSD.

Authors:  Alyson K Zalta; Philip Held; Dale L Smith; Brian J Klassen; Ashton M Lofgreen; Patricia S Normand; Michael B Brennan; Thad S Rydberg; Randy A Boley; Mark H Pollack; Niranjan S Karnik
Journal:  BMC Psychiatry       Date:  2018-07-27       Impact factor: 3.630

Review 7.  Probiotics and the Microbiota-Gut-Brain Axis: Focus on Psychiatry.

Authors:  Sabrina Mörkl; Mary I Butler; Anna Holl; John F Cryan; Timothy G Dinan
Journal:  Curr Nutr Rep       Date:  2020-09

8.  Effects of Probiotics on Cognitive Reactivity, Mood, and Sleep Quality.

Authors:  Angela Marotta; Eleonora Sarno; Antonio Del Casale; Marco Pane; Luca Mogna; Angela Amoruso; Giovanna E Felis; Mirta Fiorio
Journal:  Front Psychiatry       Date:  2019-03-27       Impact factor: 4.157

9.  Distinct Profiles of Cell-Free MicroRNAs in Plasma of Veterans with Post-Traumatic Stress Disorder.

Authors:  Min Young Lee; David Baxter; Kelsey Scherler; Taek-Kyun Kim; Xiaogang Wu; Duna Abu-Amara; Janine Flory; Rachel Yehuda; Charles Marmar; Marti Jett; Inyoul Lee; Kai Wang; Leroy Hood
Journal:  J Clin Med       Date:  2019-07-03       Impact factor: 4.241

Review 10.  Role of Microbiota-Derived Extracellular Vesicles in Gut-Brain Communication.

Authors:  Carlos M Cuesta; Consuelo Guerri; Juan Ureña; María Pascual
Journal:  Int J Mol Sci       Date:  2021-04-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.